HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Rose Sheet

Executive Summary

P&G's Lafley joins private-equity firm: Clayton, Dubilier & Rice welcomes former Procter & Gamble CEO A.G. Lafley as a special partner, according to April 7 announcement. Lafley held various positions with P&G for 32 years, including CEO for nine years, before retiring in 2009. "His experience building strong business operations, promoting innovation and spurring growth across global markets enhances our value-creation capabilities," CD&R President and CEO Donald J. Gogel notes. Lafley says he was attracted to CD&R because of its "successful history of building long-term value by improving the operational performance of its portfolio businesses exemplifies the positive role that private equity can play in the economy." Among the firm's diverse investments are companies in fields matching Lafley's industry-specific experience, such as Sally Beauty Holdings

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016888

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel